Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways
about
Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.Targeting histone deacetylases for the treatment of diseaseCombinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
P2860
Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@ast
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@en
type
label
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@ast
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@en
prefLabel
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@ast
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@en
P2093
P2860
P356
P1476
Combination phenylbutyrate/gem ...... y intrinsic apoptotic pathways
@en
P2093
Bodo Schniewind
Doris Emme
Holger Kalthoff
Kirsten Heintz
Peter Dohrmann
Roland Kurdow
P2860
P356
10.1186/1477-3163-5-25
P407
P577
2006-11-23T00:00:00Z